Related references
Note: Only part of the references are listed.Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events
Daisuke Yabe et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study
Nobuya Inagaki et al.
JOURNAL OF DIABETES INVESTIGATION (2015)
Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial
Michael E. Miller et al.
DIABETES CARE (2014)
Effect of the sodium glucose co-transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus
S. Sha et al.
DIABETES OBESITY & METABOLISM (2014)
Efficacy and safety of canagliflozin rnonotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study
Nobuya Inagaki et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Body Mass Index and Mortality Among Japanese Patients With Type 2 Diabetes: Pooled Analysis of the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial
Shiro Tanaka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Efficacy and safety of canagliflozin compared with placebo in older patients with type 2 diabetes mellitus: a pooled analysis of clinical studies
Alan Sinclair et al.
BMC ENDOCRINE DISORDERS (2014)
Dietary intake in Japanese patients with type 2 diabetes: Analysis from Japan Diabetes Complications Study
Chika Horikawa et al.
JOURNAL OF DIABETES INVESTIGATION (2014)
Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
G. E. Dailey et al.
DIABETES OBESITY & METABOLISM (2013)
Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study
N. Inagaki et al.
DIABETES OBESITY & METABOLISM (2013)
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
William T. Cefalu et al.
LANCET (2013)
Twenty-year trend of increasing obesity in young patients with poorly controlled type 2 diabetes at first diagnosis in urban Japan
Akifumi Kushiyama et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin
D. Devineni et al.
DIABETES OBESITY & METABOLISM (2012)
Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database
Ishan Hirji et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2012)
Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects
S. Sha et al.
DIABETES OBESITY & METABOLISM (2011)
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes
A. H. Barnett et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
Sumihiro Nomura et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Hypoglycaemia in Type 2 diabetes
S. A. Amiel et al.
DIABETIC MEDICINE (2008)
Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors
C Daousi et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
Energy intake and obesity in Japanese patients with type 2 diabetes
H Sone et al.
LANCET (2004)
Indexes of abdominal adiposity in patients with type 2 diabetes
E Mannucci et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Obesity and type 2 diabetes in Japanese patients
H Sone et al.
LANCET (2003)
Diet and exercise among adults with type Z diabetes
KM Nelson et al.
DIABETES CARE (2002)
Share Paper
